Kundapur Vijayananda, Cranmer-Sargison Gavin, Vachhrajani Haresh, Park-Somers Eileen, Kriegler Stefan
Saskatoon Cancer Centre, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada.
J Med Imaging Radiat Sci. 2014 Sep;45(3):218-222. doi: 10.1016/j.jmir.2014.03.093. Epub 2014 Jun 7.
The goal of this work was to analyse small bowel (SB) dose-volume following the Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC) guidelines for rectal cancer patients treated using a couch top inclined belly board (iBB). As part of this, the consistency in SB displacement was evaluated using on-treatment cone-beam computed tomographic (CBCT) imaging.
Twenty-four patients with rectal cancer were treated on a commercially available iBB. All patients went through the standard radiochemotherapy protocol in either a pre- or postoperative setup. All patients underwent weekly CBCT imaging during the course of radiation treatment. The planning computed tomographic data sets were used to analyze the quality of SB displacement, and the CBCT data sets were used to assess the reproducibility in SB displacement during treatment. The SB dose volume was evaluated and compared with QUANTEC-recommended dose limitations. Similarly, the impact of body mass index on dose volume and SB displacement was evaluated.
The SB displacement was assessed respectively as "good" and "very good" by both independent evaluating radiation oncologists. The consistency of SB displacement through the course of radiation treatment was scored as "excellent" for 22 of 24 and 23 of 24 patients by both radiation oncologists, respectively. The QUANTEC recommendation was met for all patients without bowel adhesions; however, the most benefit was observed for patients with body mass index > 23 kg/m.
Our study has shown that QUANTEC recommendations for SB dose during rectal cancer treatment can easily be met by treating patients on a couch top iBB. This technique is robust and produces consistent SB displacement.
本研究旨在依据临床正常组织效应定量分析(QUANTEC)指南,分析使用床面倾斜腹板(iBB)治疗的直肠癌患者的小肠(SB)剂量体积。作为其中一部分,利用治疗期间的锥形束计算机断层扫描(CBCT)成像评估小肠位移的一致性。
24例直肠癌患者使用市售iBB进行治疗。所有患者在术前或术后设置中均采用标准放化疗方案。所有患者在放射治疗过程中每周接受CBCT成像。利用计划计算机断层扫描数据集分析小肠位移质量,利用CBCT数据集评估治疗期间小肠位移的可重复性。评估小肠剂量体积并与QUANTEC推荐的剂量限制进行比较。同样,评估体重指数对剂量体积和小肠位移的影响。
两位独立评估的放射肿瘤学家分别将小肠位移评定为“良好”和“非常好”。两位放射肿瘤学家分别将24例患者中的22例和23例在放射治疗过程中小肠位移的一致性评为“优秀”。所有无肠粘连的患者均符合QUANTEC建议;然而,体重指数>23kg/m²的患者获益最大。
我们的研究表明,通过在床面iBB上治疗患者,直肠癌治疗期间小肠剂量的QUANTEC建议很容易实现。该技术可靠,能产生一致的小肠位移。